Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bortezomib: Understanding the Mechanism of Action

Bilal Piperdi, Yi-He Ling, Leonard Liebes, Franco Muggia, Roman Perez-Soler

Mol Cancer Ther (2011) 10 (11): 2029–2030.

https://doi.org/10.1158/1535-7163.MCT-11-0745

Published: 08 November 2011

View article titled, Bortezomib: Understanding the Mechanism of Action

Journal Articles

Multi-targeted Suppression of the RAS-AKT Signaling Network in NSCLC

Marie-E Legrier, Chia-Ping Yang, Steven Keller, Roman Perez-Soler, Susan Horwitz, Hayley McDaid

Mol Cancer Ther (2007) 6 (11_Supplement): CN07-04.

Published: 01 November 2007

View article titled, Multi-targeted Suppression of the RAS-AKT Signaling Network in NSCLC

Journal Articles

Synergistic Schedules with Combinations of EGFR Inhibitors and Cytotoxic Agents

Roman Perez-Soler

Mol Cancer Ther (2007) 6 (11_Supplement): CN07-01.

Published: 01 November 2007

View article titled, Synergistic Schedules with Combinations of EGFR Inhibitors and Cytotoxic Agents

Journal Articles

Synergism between PM02734 and erlotinib in human non-small cell lung cancer cell lines

Roman Perez-Soler, Yi-He Ling, Jose Jimeno

Mol Cancer Ther (2007) 6 (11_Supplement): C179.

Published: 01 November 2007

View article titled, Synergism between PM02734 and erlotinib in human non-small cell lung cancer cell lines

Journal Articles

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis

Yi-He Ling, Leonard Liebes, Bruce Ng, Michael Buckley, Peter J. Elliott, Julian Adams, Jian-Dong Jiang, Franco M. Muggia, Roman Perez-Soler

Mol Cancer Ther (2002) 1 (10): 841–849.

Published: 01 August 2002

View article titled, PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G<sub>2</sub>-M Phase Arrest and Apoptosis

NARROW

Bortezomib: Understanding the Mechanism of Action

Multi-targeted Suppression of the RAS-AKT Signaling Network in NSCLC

Synergistic Schedules with Combinations of EGFR Inhibitors and Cytotoxic Agents

Synergism between PM02734 and erlotinib in human non-small cell lung cancer cell lines

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis

Email alerts

AACR Journals

Bortezomib: Understanding the Mechanism of Action

Multi-targeted Suppression of the RAS-AKT Signaling Network in NSCLC

Synergistic Schedules with Combinations of EGFR Inhibitors and Cytotoxic Agents

Synergism between PM02734 and erlotinib in human non-small cell lung cancer cell lines

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G2-M Phase Arrest and Apoptosis

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis